Substitution at Phenyl Rings of Chalcone and Schiff Base Moieties Accounts for their Antiproliferative Activity

Anti-cancer Agents in Medicinal Chemistry
Marwa S SalemWael M El-Sayed

Abstract

In a continuous combat against cancer, which is one of the leading causes of mortality now, chalcone and Schiff bases moieties have been incorporated and their antiproliferative activities and associated mechanisms against liver (HepG2) and breast (MCF-7) cell lines in addition to normal fibroblasts (WI-38) have been examined. Derivatives 4 and 5 of Schiff bases only and chalcone derivatives of Schiff bases 1 and 2 were devoid of any antiproliferative activity. All three compounds (3, 6, and 7) with significant antiproliferative activity were selective and caused no growth inhibition in normal fibroblasts. Derivative 3 was a chalcone only with IC50 of ~20 µM and has a very interesting signature where it enhanced apoptosis in HepG2 by stimulating the expression of downstream execution caspase 3 without affecting neither p53 nor initiator caspase 9. In spite of the structural similarity between compounds 6 and 7, compound 6 discerned itself with a unique IC50 of ~ 10 µM. The antiproliferative activity of derivative 6 could be attributed to its unique capability of formation of free radicals such as phenoxide radicals which arrested the cell cycle through enhancing the expression of p53 and induced apoptosis by induction of both c...Continue Reading

References

Jan 5, 2002·Biochimica Et Biophysica Acta·E B YangP Mack
Apr 28, 2004·European Journal of Medicinal Chemistry·Preeti RaniAshok Kumar
Jun 30, 2004·Chemico-biological Interactions·Omid SabzevariPeter J O'Brien
May 25, 2005·International Journal of Medical Sciences·Manash K Paul, Anup K Mukhopadhyay
Jun 14, 2005·Gut·M E Guicciardi, G J Gores
Jul 9, 2005·The Journal of Pharmacology and Experimental Therapeutics·Amit Arora, Eric M Scholar
Aug 29, 2006·Nature Chemical Biology·Karson S PuttPaul J Hergenrother
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·John G WalshSeamus J Martin
Apr 1, 2009·International Journal of Molecular Sciences·Cesar EcheverriaRodrigo Ramirez-Tagle
Apr 2, 2011·Cell Death and Differentiation·M Olsson, B Zhivotovsky
Nov 15, 2012·Methods in Molecular Biology·Emir Senturk, James J Manfredi
Jan 1, 2011·Cancers·Toshinori Ozaki, Akira Nakagawara
Nov 3, 2015·Chemical & Pharmaceutical Bulletin·Marwa Sayed SalemHassan Mohamed Fawzy Madkour
Apr 5, 2016·Biological & Pharmaceutical Bulletin·Marwa Sayed Salem, Mohamed Ahmed Mohamed Ali
Dec 13, 2016·European Journal of Medicinal Chemistry·Mohamed A IsmailWael M El-Sayed
Oct 7, 2017·BMC Systems Biology·Jingchun SunHua Xu
Jun 6, 2018·International Journal of Molecular Sciences·Martina PfefferCharlotte von Gall

❮ Previous
Next ❯

Citations

Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joana MoreiraMadalena Pinto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.